Lung cancer pill which halves risk of dying from disease is hailed as game 'changing'

A "practice-changing" pill can cut the risk of dying from lung cancer by half, research has shown.

Taking the drug osimertinib after surgery dramatically reduced the risk of dying by 51%, according to the findings of an international study.

Lung cancer is one of the most common forms of cancer, with more than than 43,000 people diagnosed in the UK every year.